Overexpression of EGFR is associated with poor outcomes in various malignancies [14,15,16], including breast cancer [14,17], and EGFR overexpression is more frequently found in triple-negative/basal-like breast cancer compared to other molecular subtypes [18,19,20]. The gene discussed is EGFR; the disease is breast carcinoma.